Healthcare

Boston Scientific Corp  (NYSE: BSX) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations…

Novartis AG (NYSE:NVS) Q1 2023 Earnings Call dated Apr. 25, 2023. Corporate Participants: Samir Shah — Global Head of Investor Relations Vasant…

GE Healthcare (NYSE:GE) Q1 2023 Earnings Call dated Apr. 25, 2023.   Corporate Participants: Carolynne Borders -- Chief Investor Relations Officer Peter…

Centene Corporation (NYSE: CNC) Q1 2023 earnings call dated Apr. 25, 2023 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance and…

Rite Aid Corporation (NYSE: RAD) Q4 2023 earnings call dated Apr. 20, 2023 Corporate Participants: Byron Purcell -- Vice President of Investor…

Johnson & Johnson (NYSE: JNJ) Q1 2023 earnings call dated Apr. 18, 2023 Corporate Participants: Jessica Moore -- Vice President, Investor Relations…

UnitedHealth Group Incorporated (NYSE: UNH) Q1 2023 earnings call dated Apr. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk…

Organigram Holdings, Inc. (NASDAQ: OGI) Q2 2023 earnings call dated Apr. 12, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations…

Bio Path Holdings Inc (NASDAQ: BPTH) Q4 2022 earnings call dated Mar. 31, 2023 Corporate Participants: Will O'Connor -- Investor Relations Peter…

AngioDynamics Inc. (NASDAQ: ANGO) Q3 2023 earnings call dated Mar. 30, 2023 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer…

HEXO Corp (NYSE: HEXO) Q2 2023 earnings call dated Mar. 17, 2023 Corporate Participants: Charlie Bowman -- President and Chief Executive Officer…

Cipher Pharmaceuticals Inc (TSE: CPH) Q4 2022 earnings call dated Mar. 17, 2023 Corporate Participants: Craig Mull -- Interim Chief Executive Officer…

Cara Therapeutics Inc (NASDAQ:CARA) Q4 2022 Earnings Call dated Mar. 06, 2023. Corporate Participants: Chris Posner -- President and Chief Executive Officer…

Patterson Companies Inc (NASDAQ: PDCO) Q3 2023 earnings call dated Mar. 02, 2023 Corporate Participants: John Wright -- Vice President, Investor Relations…

ImmunoGen Inc (NASDAQ:IMGN) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Anabel Chan -- Head of Investor Relations Mark Enyedy -- President…

FibroGen Inc (NASDAQ:FGEN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Michael Tung -- Vice President, Corporate Strategy and Investor…

Medtronic PLC (NYSE: MDT) Q3 2023 earnings call dated Feb. 21, 2023 Corporate Participants: Ryan Weispfenning -- Vice President and Head of…

Sage Therapeutics Inc (NASDAQ: SAGE) Q4 2022 earnings call dated Feb. 16, 2023 Corporate Participants: Helen Rubinstein -- Director of Investor Relations…

10X Genomics Inc (NASDAQ: TXG) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Cassie Corneau -- Manager, Investor Relations and…

Biogen, Inc. (NASDAQ: BIIB) Q4 2022 earnings call dated Feb. 15, 2023 Corporate Participants: Michael Hencke -- Head of Investor Relations Christopher…

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…